Sign in
4

Changes in Ownership

PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-044506

President and CEO sold 21,120 shares at an average $56.89 ($1,201,595)

  • President and CEO acquired 100,000 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BENDHEIM JACK President and CEO 2026-04-14 Sale 10b5-1 −6,548 $59.03 $386,553 31,572 I
BENDHEIM JACK President and CEO 2026-04-14 Sale 10b5-1 −492 $59.69 $29,369 31,080 I
BENDHEIM JACK President and CEO 2026-04-15 Sale 10b5-1 −2,623 $56.27 $147,594 28,457 I
BENDHEIM JACK President and CEO 2026-04-15 Sale 10b5-1 −3,618 $57.21 $206,985 24,839 I
BENDHEIM JACK President and CEO 2026-04-15 Sale 10b5-1 −799 $58.11 $46,432 24,040 I
BENDHEIM JACK President and CEO 2026-04-16 Conversion 10b5-1 +100,000 124,040 I
BENDHEIM JACK President and CEO 2026-04-16 Sale 10b5-1 −5,190 $54.56 $283,141 118,850 I
BENDHEIM JACK President and CEO 2026-04-16 Sale 10b5-1 −1,850 $54.88 $101,520 117,000 I
Derivatives
BENDHEIM JACK President and CEO 2026-04-16 Conversion · Class B Common Stock 10b5-1 −100,000 19,496,034 I
Open-market sales · 21,120 sh · avg $56.89 · $1,201,595
Loading xslF345X06/tm2611963-1_4seq1.xml…